Pulmonx (LUNG) Change in Receivables (2019 - 2025)
Pulmonx (LUNG) posted quarterly Change in Receivables of -$1.4 million for Q3 2025, down 492.76% year-over-year from $359000.0 in Q3 2024, and down 215.57% quarter-over-quarter from $1.2 million in Q2 2025.
Pulmonx (LUNG) Change in Receivables (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Change in Receivables for 7 consecutive years, with -$1.4 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Change in Receivables fell 492.76% year-over-year to -$1.4 million; the TTM figure through Sep 2025 stood at $2.3 million (up 70.96% YoY), while the FY2024 annual figure was $1.3 million, down 57.86% from the prior year.
- Change in Receivables eased to -$1.4 million in Q3 2025 per LUNG's latest filing, from $1.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $1.8 million in Q4 2023 and bottomed at -$1.4 million in Q3 2025.
- Historically, Change in Receivables has averaged $503421.1 across 5 years, with a median of $715000.0 in 2023.
- Annual changes were most pronounced in 2023 — Change in Receivables jumped 793.41% — and 2025, when it slumped 492.76%.
- Pulmonx's Change in Receivables stood at -$387000.0 in 2021, then surged by 431.78% to $1.3 million in 2022, then soared by 37.23% to $1.8 million in 2023, then fell by 1.19% to $1.7 million in 2024, then tumbled by 180.99% to -$1.4 million in 2025.
- Business Quant data shows LUNG's Change in Receivables at -$1.4 million in Q3 2025, $1.2 million in Q2 2025, and $721000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | - |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Pulmonx | 97.63 Mn | 27.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.41 Mn |
| Sep 30, 2025 | -1.41 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 721,000.00 |
| Mar 31, 2025 | 721,000.00 |
| Dec 31, 2024 | 1.74 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 359,000.00 |
| Sep 30, 2024 | 359,000.00 |
| Jun 30, 2024 | 571,000.00 |
| Jun 30, 2024 | 571,000.00 |
| Mar 31, 2024 | -1.36 Mn |
| Mar 31, 2024 | -1.36 Mn |
| Dec 31, 2023 | 1.76 Mn |
| Dec 31, 2023 | 1.76 Mn |
| Sep 30, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 715,000.00 |
| Jun 30, 2023 | 715,000.00 |